Expression and significance P53 and P21 (WAF1/CIP1) in thyroid carcinoma

Z. Jun,H. Xiongwei,S. Qinghua
2000-01-01
Abstract:Objective: To determine expression of P53 and P21 (WAF1/CIP1) in thyroid carcinomas and its relationship to development and prognosis of the carcinoma. Methods: 90 cases of thyroid tissues (60 thyroid carcinomas, 10 thyroid adenomas, 10 goitres and 10 normal thyroid tissues) were studied by SP immunohistochemical method. Results: Positive immunoreactivity of P53 and P21 (WAF1/CIP1) was found only in thyroid carcinomas, the positive rate of the P53 and P21 is 53.3% and 41.7%. The positive-staining rates of P53 were higher in cases of undifferentiated carcinomas, positive metastasis, lymph nodes or at tumor stage III, IV than in the cases of well-differentiated, no metastasis lymph nodes, or at tumor stage I, II. In addition to, the positive-staining of P21 (WAF1/CIP1) were lower in cases of undifferentiated carcinomas, positive metastasis lymph nodes or at tumor stage III, IV than in the cases of well-differentiated, no metastasis lymph nodes, or at tumor stage I, II. The P21 (WAF1/CIP1) expression rate in the P53 positive group was lower than that of the P53 negative group (P < 0.05). Conclusion: The expression of P21 (WAF1/CIP1) protein in thyroid cancer is related with P53-depend pathway and P53-independent pathway, mainly the P53-depend pathway. Examination of expression of P53 and P21 (WAF1/CIP1) proteins may be helpful to judge the thyroid cancer's behavior and prognosis.
What problem does this paper attempt to address?